EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Retrospective study of postoperative survival of keratinocyte‐derived skin cancer patients at the end of life

Mahya Ahmadipour, Melitta Kitzwögerer, Franz Trautinger iD

JDDG: Journal der Deutschen Dermatologischen Gesellschaft · 2024

DOI: 10.1111/ddg.15482 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2024. Verfasst von Mahya Ahmadipour und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venereology, University Hospital of Sankt Pölten, Karl Landsteiner University of Health Sciences, St. Pölten, Austria. Hauptthemen laut MEDLINE: Skin Neoplasms, Carcinoma, Squamous Cell, Basal Cell Carcinoma, Keratinocytes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and objectives Basal and squamous cell carcinoma (BCC, SCC), collectively referred to as keratinocyte‐derived skin cancer (KC), are the most common human cancers worldwide. Surgery is the treatment of choice, but may represent overtreatment in the very elderly. This study aims to address this issue by investigating the life expectancy of patients over 80 years after surgery. Patients and methods A single‐center, retrospective study was performed to include surgically treated KC patients at the Department of Dermatology and Venereology of the University Hospital in St. Pölten, Austria, between 01.01.2011 and 31.12.2017, who were 80 years or older. Data on individual survival (cut‐off April 30, 2020), date and cause of death were retrieved from the Austrian national demographic database at Statistics Austria (Vienna).

Results

940 patients (450 female, 490 male, 639 BCCs, 301 SCCs) were included with 307 being alive at the cut‐off date. Median postoperative survival was 57 months (95% CI, 54–63 months).

Conclusions

With a median postoperative survival of almost 5 years, surgery remains a valid treatment option for KC at the end of life. However, 77 of the treated patients died within a year after surgery and preoperative assessment might have helped to avoid overtreatment in some of these cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Skin NeoplasmsCarcinoma, Squamous CellBasal Cell CarcinomaKeratinocytesHumansFemaleMaleRetrospective StudiesAged, 80 and overAustriaLife Expectancy

Stichwörter der Autor:innen

Basal cell carcinomaGeriatricsSkin cancerSquamous cell carcinomaSurvival

Autor:innen und Institutionen

  • Department of Dermatology and Venereology, University Hospital of Sankt Pölten, Karl Landsteiner University of Health Sciences, St. Pölten, Austria.
  • Karl Landsteiner Institute of Dermatological Research, St. Pölten, Austria.
  • Clinical Institute of Pathology, University Hospital of Sankt Pölten, Karl Landsteiner University of Health Sciences, St. Pölten, Austria.

ORCID-Profile: Franz Trautinger

Zitieren

APA

Ahmadipour, M., Kitzwögerer, M., & Trautinger, F. (2024). Retrospective study of postoperative survival of keratinocyte‐derived skin cancer patients at the end of life. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. https://doi.org/10.1111/ddg.15482

Vancouver

Ahmadipour M, Kitzwögerer M, Trautinger F. Retrospective study of postoperative survival of keratinocyte‐derived skin cancer patients at the end of life. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2024. doi:10.1111/ddg.15482

BibTeX
@article{Ahmadipour2024,
  author = {Ahmadipour, Mahya and Kitzwögerer, Melitta and Trautinger, Franz},
  title = {Retrospective study of postoperative survival of keratinocyte‐derived skin cancer patients at the end of life},
  journal = {JDDG: Journal der Deutschen Dermatologischen Gesellschaft},
  year = {2024},
  doi = {10.1111/ddg.15482}
}
Kostenlos starten →